A prospective, multicenter, nationwide, observational study of flecainide controlled release on the quality of life of patients with atrial fibrillation in Greece, the REFLEC-CR study

3 September 2019 (17:15 - 17:32)
Organised by:
Congress Presentation Part of: Anti-arrhythmic drug therapy: new concepts on old drugs Antiarrhythmic Pharmacotherapy ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by